The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Lourdes Ibáñez

Hospital Sant Joan de Déu

University of Barcelona

Passeig de Sant Joan de Déu

2, 08950 Esplugues

Spain

[email]@hsjdbcn.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Hospital Sant Joan de Déu, University of Barcelona, Passeig de Sant Joan de Déu, 2, 08950 Esplugues, Spain. 2012
  • Corresponding author: Lourdes Ibáñez. 2012
  • Endocrinology Unit, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain. 2000 - 2011
  • University of Barcelona, Spain. 2006

References

  1. Ethinyl Estradiol-Cyproterone Acetate Versus Low-Dose Pioglitazone-Flutamide-Metformin for Adolescent Girls with Androgen Excess: Divergent Effects on CD163, TWEAK Receptor, ANGPTL4, and LEPTIN Expression in Subcutaneous Adipose Tissue. Díaz, M., Chacón, M.R., López-Bermejo, A., Maymó-Masip, E., Salvador, C., Vendrell, J., de Zegher, F., Ibáñez, L. J. Clin. Endocrinol. Metab. (2012) [Pubmed]
  2. Abundance of circulating preadipocyte factor 1 in early life. de Zegher, F., Díaz, M., Sebastiani, G., Martín-Ancel, A., Sánchez-Infantes, D., López-Bermejo, A., Ibáñez, L. Diabetes. Care (2012) [Pubmed]
  3. Endocrinology and gynecology of girls and women with low birth weight. Ibáñez, L., López-Bermejo, A., Díaz, M., Marcos, M.V. Fetal. Diagn. Ther. (2011) [Pubmed]
  4. Treatment of androgen excess in adolescent girls: ethinylestradiol-cyproteroneacetate versus low-dose pioglitazone-flutamide-metformin. Ibáñez, L., Diaz, M., Sebastiani, G., Sánchez-Infantes, D., Salvador, C., Lopez-Bermejo, A., de Zegher, F. J. Clin. Endocrinol. Metab. (2011) [Pubmed]
  5. Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence. Ibáñez, L., López-Bermejo, A., Díaz, M., Marcos, M.V., de Zegher, F. J. Clin. Endocrinol. Metab. (2011) [Pubmed]
  6. Early metformin therapy to delay menarche and augment height in girls with precocious pubarche. Ibáñez, L., Lopez-Bermejo, A., Diaz, M., Marcos, M.V., de Zegher, F. Fertil. Steril. (2011) [Pubmed]
  7. Low-dose pioglitazone, flutamide, metformin plus an estro-progestagen for non-obese young women with polycystic ovary syndrome: increasing efficacy and persistent safety over 30 months. Ibáñez, L., López-Bermejo, A., Díaz, M., Enríquez, G., Del Río, L., De Zegher, F. Gynecol. Endocrinol. (2010) [Pubmed]
  8. Growth hormone therapy in short children born small for gestational age: effects on abdominal fat partitioning and circulating follistatin and high-molecular-weight adiponectin. Ibáñez, L., Lopez-Bermejo, A., Díaz, M., Jaramillo, A., Marín, S., de Zegher, F. J. Clin. Endocrinol. Metab. (2010) [Pubmed]
  9. Low body adiposity and high leptinemia in breast-fed infants born small-for-gestational-age. Ibáñez, L., Sebastiani, G., Diaz, M., Gómez-Roig, M.D., Lopez-Bermejo, A., de Zegher, F. J. Pediatr. (2010) [Pubmed]
  10. Pubertal metformin therapy to reduce total, visceral, and hepatic adiposity. Ibáñez, L., Lopez-Bermejo, A., Diaz, M., Marcos, M.V., de Zegher, F. J. Pediatr. (2010) [Pubmed]
  11. Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months. Ibáñez, L., López-Bermejo, A., Díaz, M., Enríquez, G., del Río, L., de Zegher, F. Clin. Endocrinol. (Oxf) (2009) [Pubmed]
  12. Clinical spectrum of premature pubarche: links to metabolic syndrome and ovarian hyperandrogenism. Ibáñez, L., Díaz, R., López-Bermejo, A., Marcos, M.V. Rev. Endocr. Metab. Disord (2009) [Pubmed]
  13. Abdominal fat partitioning and high-molecular-weight adiponectin in short children born small for gestational age. Ibáñez, L., López-Bermejo, A., Díaz, M., Marcos, M.V., Casano, P., de Zegher, F. J. Clin. Endocrinol. Metab. (2009) [Pubmed]
  14. Low-birth weight children develop lower sex hormone binding globulin and higher dehydroepiandrosterone sulfate levels and aggravate their visceral adiposity and hypoadiponectinemia between six and eight years of age. Ibáñez, L., Lopez-Bermejo, A., Díaz, M., Suárez, L., de Zegher, F. J. Clin. Endocrinol. Metab. (2009) [Pubmed]
  15. High-molecular-weight adiponectin in children born small- or appropriate-for-gestational-age. Ibáñez, L., Lopez-Bermejo, A., Diaz, M., Angulo, M., Sebastiani, G., de Zegher, F. J. Pediatr. (2009) [Pubmed]
  16. Visceral adiposity without overweight in children born small for gestational age. Ibáñez, L., Lopez-Bermejo, A., Suárez, L., Marcos, M.V., Díaz, M., de Zegher, F. J. Clin. Endocrinol. Metab. (2008) [Pubmed]
  17. Polycystic ovaries in nonobese adolescents and young women with ovarian androgen excess: relation to prenatal growth. Ibáñez, L., López-Bermejo, A., Callejo, J., Torres, A., Cabré, S., Dunger, D., de Zegher, F. J. Clin. Endocrinol. Metab. (2008) [Pubmed]
  18. Early development of visceral fat excess after spontaneous catch-up growth in children with low birth weight. Ibáñez, L., Suárez, L., Lopez-Bermejo, A., Díaz, M., Valls, C., de Zegher, F. J. Clin. Endocrinol. Metab. (2008) [Pubmed]
  19. Metformin treatment for four years to reduce total and visceral fat in low birth weight girls with precocious pubarche. Ibáñez, L., López-Bermejo, A., Díaz, M., Marcos, M.V., de Zegher, F. J. Clin. Endocrinol. Metab. (2008) [Pubmed]
  20. Gender specificity of body adiposity and circulating adiponectin, visfatin, insulin, and insulin growth factor-I at term birth: relation to prenatal growth. Ibáñez, L., Sebastiani, G., Lopez-Bermejo, A., Díaz, M., Gómez-Roig, M.D., de Zegher, F. J. Clin. Endocrinol. Metab. (2008) [Pubmed]
  21. Pubertal adiposity after fetal growth restraint: toward a calorie restriction mimetic approach. Ibáñez, L., López-Bermejo, A., de Zegher, F. Metab. Clin. Exp. (2008) [Pubmed]
  22. Pioglitazone (7.5 mg/day) added to flutamide-metformin in women with androgen excess: additional increments of visfatin and high molecular weight adiponectin. Ibáñez, L., López-Bermejo, A., Díaz, M., Enríquez, G., Valls, C., de Zegher, F. Clin. Endocrinol. (Oxf) (2008) [Pubmed]
  23. Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess. Ibáñez, L., López-Bermejo, A., del Rio, L., Enríquez, G., Valls, C., de Zegher, F. J. Clin. Endocrinol. Metab. (2007) [Pubmed]
  24. Polycystic ovaries after precocious pubarche: relation to prenatal growth. Ibáñez, L., Jaramillo, A., Enríquez, G., Miró, E., López-Bermejo, A., Dunger, D., de Zegher, F. Hum. Reprod. (2007) [Pubmed]
  25. Puberty and prenatal growth. Ibáñez, L., de Zegher, F. Mol. Cell. Endocrinol. (2006) [Pubmed]
  26. Puberty after prenatal growth restraint. Ibáñez, L., de Zegher, F. Horm. Res. (2006) [Pubmed]
  27. Discontinuous low-dose flutamide-metformin plus an oral or a transdermal contraceptive in patients with hyperinsulinaemic hyperandrogenism: normalizing effects on CRP, TNF-alpha and the neutrophil/lymphocyte ratio. Ibáñez, L., Valls, C., de Zegher, F. Hum. Reprod. (2006) [Pubmed]
  28. Early puberty-menarche after precocious pubarche: relation to prenatal growth. Ibáñez, L., Jiménez, R., de Zegher, F. Pediatrics (2006) [Pubmed]
  29. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women. Ibáñez, L., de Zegher, F. Hum. Reprod. Update (2006) [Pubmed]
  30. Metformin therapy during puberty delays menarche, prolongs pubertal growth, and augments adult height: a randomized study in low-birth-weight girls with early-normal onset of puberty. Ibáñez, L., Valls, C., Ong, K., Dunger, D.B., de Zegher, F. J. Clin. Endocrinol. Metab. (2006) [Pubmed]
  31. Early development of adiposity and insulin resistance after catch-up weight gain in small-for-gestational-age children. Ibáñez, L., Ong, K., Dunger, D.B., de Zegher, F. J. Clin. Endocrinol. Metab. (2006) [Pubmed]
  32. Metformin treatment to prevent early puberty in girls with precocious pubarche. Ibáñez, L., Ong, K., Valls, C., Marcos, M.V., Dunger, D.B., de Zegher, F. J. Clin. Endocrinol. Metab. (2006) [Pubmed]
  33. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in nonobese adolescents and women. Ibáñez, L., de Zegher, F. Fertil. Steril. (2006) [Pubmed]
  34. Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy. Ibáñez, L., de Zegher, F. J. Clin. Endocrinol. Metab. (2005) [Pubmed]
  35. Neutrophil count in small-for-gestational age children: contrasting effects of metformin and growth hormone therapy. Ibáñez, L., Fucci, A., Valls, C., Ong, K., Dunger, D., de Zegher, F. J. Clin. Endocrinol. Metab. (2005) [Pubmed]
  36. Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women. Ibáñez, L., Jaramillo, A., Ferrer, A., de Zegher, F. Hum. Reprod. (2005) [Pubmed]
  37. High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception. Ibáñez, L., Jaramillo, A.M., Ferrer, A., de Zegher, F. Hum. Reprod. (2005) [Pubmed]
  38. Hyperandrogenism and excess weight gain. Ibáñez, L., Ferrer, A., Marcos, M.V. J. Pediatr. Endocrinol. Metab. (2005) [Pubmed]
  39. Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome. Ibáñez, L., Ferrer, A., Ong, K., Amin, R., Dunger, D., de Zegher, F. J. Pediatr. (2004) [Pubmed]
  40. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity. Ibáñez, L., de Zegher, F. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  41. Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity. Ibáñez, L., De Zegher, F. Hum. Reprod. (2004) [Pubmed]
  42. Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment. Ibáñez, L., Valls, C., Marcos, M.V., Ong, K., Dunger, D.B., De Zegher, F. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  43. Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide. Ibáñez, L., Valls, C., Cabré, S., De Zegher, F. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  44. Low-dose combination of flutamide, metformin and an oral contraceptive for non-obese, young women with polycystic ovary syndrome. Ibáñez, L., de Zegher, F. Hum. Reprod. (2003) [Pubmed]
  45. Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism. Ibáñez, L., Ong, K., Ferrer, A., Amin, R., Dunger, D., de Zegher, F. J. Clin. Endocrinol. Metab. (2003) [Pubmed]
  46. Hypergonadotrophinaemia with reduced uterine and ovarian size in women born small-for-gestational-age. Ibáñez, L., Potau, N., Enriquez, G., Marcos, M.V., de Zegher, F. Hum. Reprod. (2003) [Pubmed]
  47. Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception. Ibáñez, L., De Zegher, F. J. Clin. Endocrinol. Metab. (2003) [Pubmed]
  48. Plasminogen activator inhibitor-1 in girls with precocious pubarche: a premenarcheal marker for polycystic ovary syndrome?. Ibáñez, L., Aulesa, C., Potau, N., Ong, K., Dunger, D.B., de Zegher, F. Pediatr. Res. (2002) [Pubmed]
  49. Hypersecretion of FSH in infant boys and girls born small for gestational age. Ibáñez, L., Valls, C., Cols, M., Ferrer, A., Marcos, M.V., De Zegher, F. J. Clin. Endocrinol. Metab. (2002) [Pubmed]
  50. Early menarche and subclinical ovarian hyperandrogenism in girls with reduced adult height after low birth weight. Ibáñez, L., Valls, C., Miró, E., Marcos, M.V., de Zegher, F. J. Pediatr. Endocrinol. Metab. (2002) [Pubmed]
  51. Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation. Ibáñez, L., Valls, C., Ferrer, A., Ong, K., Dunger, D.B., De Zegher, F. J. Clin. Endocrinol. Metab. (2002) [Pubmed]
  52. Reduced ovulation rate in adolescent girls born small for gestational age. Ibáñez, L., Potau, N., Ferrer, A., Rodriguez-Hierro, F., Marcos, M.V., de Zegher, F. J. Clin. Endocrinol. Metab. (2002) [Pubmed]
  53. Anovulation in eumenorrheic, nonobese adolescent girls born small for gestational age: insulin sensitization induces ovulation, increases lean body mass, and reduces abdominal fat excess, dyslipidemia, and subclinical hyperandrogenism. Ibáñez, L., Potau, N., Ferrer, A., Rodriguez-Hierro, F., Marcos, M.V., De Zegher, F. J. Clin. Endocrinol. Metab. (2002) [Pubmed]
  54. Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism. Ibáñez, L., Valls, C., Ferrer, A., Marcos, M.V., Rodriguez-Hierro, F., de Zegher, F. J. Clin. Endocrinol. Metab. (2001) [Pubmed]
  55. Polycystic ovary syndrome after precocious pubarche: ontogeny of the low-birthweight effect. Ibáñez, L., Valls, C., Potau, N., Marcos, M.V., de Zegher, F. Clin. Endocrinol. (Oxf) (2001) [Pubmed]
  56. Treatment of hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism in nonobese, adolescent girls: effect of flutamide. Ibáñez, L., Potau, N., Marcos, M.V., de Zegher, F. J. Clin. Endocrinol. Metab. (2000) [Pubmed]
  57. Adrenal hyperandrogenism in adolescent girls with a history of low birthweight and precocious pubarche. Ibáñez, L., Potau, N., Marcos, M.V., De Zegher, F. Clin. Endocrinol. (Oxf) (2000) [Pubmed]
  58. Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche. Ibáñez, L., Valls, C., Potau, N., Marcos, M.V., de Zegher, F. J. Clin. Endocrinol. Metab. (2000) [Pubmed]
  59. Early puberty: rapid progression and reduced final height in girls with low birth weight. Ibáñez, L., Ferrer, A., Marcos, M.V., Hierro, F.R., de Zegher, F. Pediatrics (2000) [Pubmed]
  60. Precocious pubarche in girls and the development of androgen excess. Ibáñez, L., Potau, N., Dunger, D., de Zegher, F. J. Pediatr. Endocrinol. Metab. (2000) [Pubmed]
  61. Increased bone mineral density and serum leptin in non-obese girls with precocious pubarche: relation to low birthweight and hyperinsulinism. Ibáñez, L., Potau, N., Ong, K., Dunger, D.B., De Zegher, F. Horm. Res. (2000) [Pubmed]
 
WikiGenes - Universities